3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 1
1
Status
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Rhabdoid Tumor
1
Recurrence
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
21
fludarabine
17
Specimen Handling
13
Magnetic Resonance Spectroscopy
10
pembrolizumab
9
Nivolumab
9
Radiotherapy
7
Cisplatin
7
fludarabine phosphate
5
Injections
5
tislelizumab
4
daratumumab
4
Rituximab
4
Paclitaxel
4
Ipilimumab
4
Interleukin-2
4
Immune Checkpoint Inhibitors
4
Gemcitabine
4
Fluorouracil
4
Drug Therapy
4
Doxorubicin
4
Dexamethasone
4
Carboplatin
4
Biopsy
4
venetoclax
3
toripalimab
3
X-Rays
3
Radiosurgery
3
Platinum
3
Oxaliplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Not yet recruiting
×
gallium maltolate
×
Clear all
NCT07331064
2026-01-09
GABRIEL
Medical College of Wisconsin
Phase 1
Not yet recruiting
15 enrolled